insights_auto
Why is ZLDPF down 2,21%?
Dive Deeperchevron_right
ZLDPF:OTCMKTS
Zealand Pharma A/S
34,60 USD
arrow_downward
-2,21%(-0,78) 1D
6-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZLDPF...
Open
34,60 USD
High
34,60 USD
Low
34,60 USD
Mkt. cap
2,49 млд
Avg. vol.
403,00
Volume
0,00
52-wk high
83,12 USD
52-wk low
33,08 USD
Beta
1,25
Shares outstanding
71,61 млн
No. of employees
578
Open
34,60 USD
High
34,60 USD
Low
34,60 USD
Mkt. cap
2,49 млд
Avg. vol.
403,00
Volume
0,00
52-wk high
83,12 USD
52-wk low
33,08 USD
Beta
1,25
Shares outstanding
71,61 млн
No. of employees
578
News stories
From web sources and news partners
Benzinga
·
30 мүнөт мурун
Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week
Yahoo Finance
·
1 саат мурун
Microsoft (MSFT) Makes the 10 Best Dow Stocks for 2027 List as Azure Growth Speeds Up
Bloomberg.com
·
1 күн мурун
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
Founded1997-ж., 1-апр.
Headquarters-
SectorHealth Care
Industry-
Websitezealandpharma.com